Search
Patexia Research
Case number 1:17-cv-01287

Forest Laboratories, LLC et al v. Breckenridge Pharmaceutical, Inc. > Documents

Date Field Doc. No.Description (Pages)
Nov 18, 2020 N/A Terminated Case (0)
Docket Text: CASE CLOSED per DI# [18]. (cna, )
Oct 20, 2020 18 Judgment (7)
Docket Text: FINAL JUDGMENT. Signed by Judge Mitchell S. Goldberg on 10/19/2020. Associated Cases: 1:14-cv-01119-MSG et al.(nmg)
Oct 16, 2020 17 Proposed Order (7)
Docket Text: PROPOSED ORDER -- Agreed Upon Final Judgment by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (Tigan, Jeremy)
Jun 18, 2019 16 Notice (Other) (1)
Docket Text: NOTICE of Withdrawal of Sara Elizabeth Bussiere as Counsel by Breckenridge Pharmaceutical, Inc. (Bussiere, Sara)
Aug 15, 2018 15 Letter (1)
Docket Text: Letter to Counsel from Judge Goldberg regarding Delaware Case Assignments. (gvw)
Dec 14, 2017 14 Order (4)
Docket Text: ORDER approving [13] Stipulation and Order (regarding agreement to be bound and to stay). ORDER STAYING CASE pending the outcome of Breckenridge's Appeal and Forest's Cross-Appeal, including any review by the United States Supreme Court. See order for further details. Signed by Judge Mitchell S. Goldberg on 12/14/2017. (nmfn)
Dec 11, 2017 13 Stipulation (4)
Docket Text: STIPULATION and Order (regarding agreement to be bound and to stay) by Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (Noreika, Maryellen)
Nov 27, 2017 12 Order (2)
Docket Text: ORDER approving [11] Joint STIPULATION TO EXTEND TIME to Respond to Complaint to December 11, 2017 filed by Breckenridge Pharmaceutical, Inc., Set/Reset Answer Deadlines: Breckenridge Pharmaceutical, Inc. answer due 12/11/2017. Signed by Judge Mitchell S. Goldberg on 11/27/2017. (fms)
Nov 22, 2017 11 Stipulation to EXTEND Time (2)
Docket Text: Joint STIPULATION TO EXTEND TIME to Respond to Complaint to December 11, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Brauerman, Stephen)
Nov 14, 2017 10 Order (2)
Docket Text: ORDER granting [9] STIPULATION TO EXTEND TIME to Move, Answer, or otherwise Respond to the Complaint for Patent Infringement to November 27, 2017 filed by Breckenridge Pharmaceutical, Inc., Set/Reset Answer Deadlines: Breckenridge Pharmaceutical, Inc. answer due 11/27/2017. Signed by Judge Mitchell S. Goldberg on 11/13/2017. (nmfn)
Nov 9, 2017 9 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to Move, Answer, or otherwise Respond to the Complaint for Patent Infringement to November 27, 2017 - filed by Breckenridge Pharmaceutical, Inc.. (Brauerman, Stephen)
Sep 26, 2017 7 Request for Waiver of Service (1)
Docket Text: REQUEST FOR WAIVER of Service sent to Breckenridge Pharmaceutical, Inc. on 9/11/2017 by Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. Waiver of Service due by 10/11/2017. (Noreika, Maryellen)
Sep 26, 2017 8 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE returned executed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd.: For Breckenridge Pharmaceutical, Inc. waiver sent on 9/11/2017, answer due 11/13/2017. (Noreika, Maryellen)
Sep 25, 2017 6 Order (1)
Docket Text: 12(b) PROCEDURAL ORDER. See order for details. Signed by Judge Mitchell S. Goldberg on 9/25/2017. (nmfn)
Sep 13, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb)
Sep 11, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical, Inc. on 9/11/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn)
Sep 8, 2017 1 Exhibits A & B (9)
Sep 8, 2017 1 Civil Cover Sheet (1)
Sep 8, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn)
Sep 8, 2017 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/28/2017. Date of Expiration of Patent: 6/9/2020. Thirty Month Stay Deadline: 1/28/2020. (nmfn)
Sep 8, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,763,476. (nmfn)
Sep 8, 2017 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc for Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC filed by Forest Laboratories Holdings, Ltd., Forest Laboratories, LLC. (nmfn)
Sep 8, 2017 1 Complaint* (1)
Menu